Biswas, M <br/><br/>
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas.  [electronic resource] 

 -  Clinical endocrinology  Jul 2005 
 - 26-31 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0300-0664 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2265.2005.02293.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Bromocriptine--therapeutic use<br/>Cabergoline<br/>Dopamine Agonists--therapeutic use<br/>Ergolines--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pituitary Neoplasms--drug therapy<br/>Prolactinoma--drug therapy<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome